Biochemical premotor biomarkers for Parkinson's disease

被引：28

作者：

Mollenhauer, Brit ^{[1
,2
]}

Zhang, Jing ^{[3
]}

机构：

[1] Paracelsus Elena Klin, D-34128 Kassel, Germany

[2] Univ Gottingen, Kassel, Germany

[3] Univ Washington, Dept Pathol, Seattle, WA 98195 USA

来源：

MOVEMENT DISORDERS | 2012年 / 27卷 / 05期

关键词：

biomarkers; genomics; metabolomics; Parkinson's disease; premotor; proteomics; HUMAN CEREBROSPINAL-FLUID; ALPHA-SYNUCLEIN; GENE-EXPRESSION; URIC-ACID; ALZHEIMER; PROTEIN; URATE; DJ-1; CSF; PROTEOMICS;

D O I：

10.1002/mds.24956

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathologic processes or of pharmacologic responses to a therapeutic intervention. We reviewed the current status of target protein biomarkers (eg, total/oligomeric a-synuclein and DJ-1) in cerebrospinal fluid, as well as on unbiased processes that can be used to discover novel biomarkers. We have also provide ddetails about strategies toward potential populations/models and technologies, including the need for standardized sampling techniques, to pursue the identification of new biochemical markers in the premotor stage of Parkinson's disease in the future. (C) 2012 Movement Disorder Society

引用

页码：644 / 650

页数：7

共 50 条

[31] Biomarkers and Parkinson's disease
Michell, AW
Lewis, SJG
Foltynie, T
Barker, RA
BRAIN, 2004, 127 : 1693 - 1705
[32] In search of Parkinson's disease biomarkers - is the answer in our mouths? A systematic review of the literature on salivary biomarkers of Parkinson's disease
Figura, Monika
Friedman, Andrzej
NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (01) : 14 - 20
[33] miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease
Mushtaq, Gohar
Greig, Nigel H.
Anwar, Firoz
Zamzami, Mazin A.
Choudhry, Hani
Shaik, Munvar M.
Tamargo, Ian A.
Kamal, Mohammad A.
MEDICINAL CHEMISTRY, 2016, 12 (03) : 217 - 225
[34] Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program
Gwinn, Katrina
David, Karen K.
Swanson-Fischer, Christine
Albin, Roger
St Hillaire-Clarke, Coryse
Sieber, Beth-Anne
Lungu, Codrin
Bowman, F. DuBois
Alcalay, Roy N.
Babcock, Debra
Dawson, Ted M.
Dewey, Richard B., Jr.
Foroud, Tatiana
German, Dwight
Huang, Xuemei
Petyuk, Vlad
Potashkin, Judith A.
Saunders-Pullman, Rachel
Sutherland, Margaret
Walt, David R.
West, Andrew B.
Zhang, Jing
Chen-Plotkin, Alice
Scherzer, Clemens R.
Vaillancourt, David E.
Rosenthal, Liana S.
BIOMARKERS IN MEDICINE, 2017, 11 (06) : 451 - 473
[35] Pursuing Multiple Biomarkers for Early Idiopathic Parkinson's Disease Diagnosis
Gopar-Cuevas, Yareth
Duarte-Jurado, Ana P.
Diaz-Perez, Rosa N.
Saucedo-Cardenas, Odila
Loera-Arias, Maria J.
Montes-de-Oca-Luna, Roberto
Rodriguez-Rocha, Humberto
Garcia-Garcia, Aracely
MOLECULAR NEUROBIOLOGY, 2021, 58 (11) : 5517 - 5532
[36] An update on new-age potential biomarkers for Parkinson's disease
Soni, Ritu
Mathur, Kirti
Shah, Jigna
AGEING RESEARCH REVIEWS, 2024, 94
[37] Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration
Fasano, Mauro
Alberio, Tiziana
Lopiano, Leonardo
BIOMARKERS IN MEDICINE, 2008, 2 (05) : 465 - 478
[38] Proteomics Approaches to Parkinson's Disease and Search for Potential Biomarkers: Review
Kasap, Murat
Akpinar, Gurler
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2011, 31 (03): : 691 - 701
[39] Plasma-Based Circulating MicroRNA Biomarkers for Parkinson's Disease
Khoo, Sok Kean
Petillo, David
Kang, Un Jung
Resau, James H.
Berryhill, Brian
Linder, Jan
Forsgren, Lars
Neuman, Leslie A.
Tan, Aik Choon
JOURNAL OF PARKINSONS DISEASE, 2012, 2 (04) : 321 - 331
[40] A Systems Model of Parkinson's Disease Using Biochemical Systems Theory
Sasidharakurup, Hemalatha
Melethadathil, Nidheesh
Nair, Bipin
Diwakar, Shyam
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2017, 21 (08) : 454 - 464

← 1 2 3 4 5 →